Article
Clinical Characteristics of Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions
2021-06-22
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> Epidermal growth factor receptor (EGFR) exon 20 insertion mutations account for 4%–10% of all EGFR mutations in patients with non-small cell lung cancer (NSCLC). However, data on the differences in clinical characteristics between patients with EGFR exon 20 insertion mutations and major mutations (exon 19 deletion and L858R) are limited. <bold>Methods:</bold> We...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9a7c84b8-1668-5407-9cfd-f9375f25fdec
- DOI
- 10.21203/rs.3.rs-609572/v1
